Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Thoracic 2Sarcoma 1Genitourinary 1Breast 1

Conditions

Breast Neoplasms 5Ovarian Neoplasms 3Carcinoma, Ovarian Epithelial 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Drug-Related Side Effects and Adverse Reactions 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Small Cell Lung Carcinoma 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1

Interventions

eribulin 1Trastuzumab 1Paclitaxel 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Ginkgo Extract 1Fluorodeoxyglucose F18 1Exercise Therapy 1Doxorubicin 1Docetaxel 1Cycloserine 1Cyclophosphamide 1Carnitine 1Carboplatin 1Aromatase Inhibitors 1Amifostine 1Acupuncture Therapy 12,2'-dithiodiethanesulfonic acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Amifostine × Breast × Clear all
NCT00078845 2012-10-17

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Completed
24 enrolled
BreastGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Neurotoxicity Syndromes, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡